Higher-dose Wegovy could increase patient expectation, warns PDA
Abstract
The Pharmacists’ Defence Association (PDA) has said prescribers should not feel “pushed toward any specific medicine or dose”, following UK approval of a 7.2mg dose of Wegovy (semaglutide; Novo Nordisk). On 6 January 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) licensed the new dosage of Wegovy, which is three times higher than the […]
Fields of Study & Subjects
Pharmacology and Obesity Treatment
Diabetes Treatment and Management
Pharmaceutical industry and healthcare
Publication details
- Journal / source
- Pharmaceutical journal/The pharmaceutical journal
- Publication date
- 1 January 2026